Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00134654
Status:
COMPLETED
Last Update Posted:
2011-06-16
First Post:
2005-08-24
Brief Title:
Two Doses of Conjugated Estrogen Premarin in Patients With Androgen-Independent Prostate Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
02-306
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dana-Farber Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Mark Pomerantz MD
Old Organization:
Dana-Farber Cancer Institute
Collaborators
| Name | Class |
|---|---|
| Saint Annes Hospital | OTHER |
| Beth Israel Deaconess Medical Center | OTHER |
| Massachusetts General Hospital | OTHER |
| Brigham and Womens Hospital | OTHER |
| Lowell General Hospital | OTHER |
| South Shore Hospital | OTHER |
| Emerson Hospital Concord MA | OTHER |